Schwab, D. ., Sturm, C. ., Portron, A. ., Fuerst-Recktenwald, S. ., Hainzl, D. ., Jordan, P. ., … DuBiner, H. . Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ Open Ophthalmology, 1(1), e000063. https://doi.org/10.1136/bmjophth-2016-000063 (Original work published 2017)